Literature DB >> 20052912

[New betulin derivatives in combination with rimantadine for inhibition of influenza virus reproduction].

O V Savinova, N I Pavlova, E I Boreko.   

Abstract

The preliminary studies mainly revealed comparable inhibition activities of 3-oxime of betulonic acid, 3beta-O-acetyl-28-O-hemiphthalate of betulin and 3,28-dioxime of betulin against reproduction of influenza viruses A (H1N1), A (H7N1), A (H3N2) and B, as well as against the strains of influenza virus A (H1N1) with intrinsic resistance to rimantadine and A (H7N1) with acquired resistance to the drug. The level of the activity depended on the system used for the virus reproduction. The highest level was observed under conditions providing higher permissibivity, i.e. in the chick embryo fibroblast cell culture for A (H7N1) and in fragments of chick embryo chorioallantoic membranes (for all the viruses). In the experiments with virus A/FPV/Rostock/34 (H7N1) in the chick embryo fibroblast cell culture the average effective concentrations (EC50) of the triterpene compounds were 10.4-17.5 mcM in comparison to EC50 of rimantadine (0.014 mcM). The use of every of the compounds in combination with rimantadine resulted in a 2-16 times decrease of their EC50 and correction of the concentration-effect relation of rimantadine. However, when rimantadine was used alone within the higher range of the nontoxic concentrations (11.6-57.6 mcM). its antiviral properties were significantly less pronounced. As a result the virus titer difference in comparison to the control within the above range of the rimantadine concentrations increased from < 1 to > 2.35 Ig PPU/ml and the relations of the maximal tolerance concentrations of the compounds to their EC50 increased 1.7-15.9 times.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20052912

Source DB:  PubMed          Journal:  Antibiot Khimioter        ISSN: 0235-2990


  2 in total

1.  Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.

Authors:  Justyna Kutkowska; Leon Strzadala; Andrzej Rapak
Journal:  Cancer Sci       Date:  2017-09-19       Impact factor: 6.716

2.  Evaluation of A-azepano-triterpenoids and related derivatives as antimicrobial and antiviral agents.

Authors:  Oxana Kazakova; Elena Tret'yakova; Dmitry Baev
Journal:  J Antibiot (Tokyo)       Date:  2021-07-12       Impact factor: 2.649

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.